New Zealand markets closed

Kiniksa Pharmaceuticals, Ltd. (KNSA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
19.68-0.51 (-2.53%)
As of 01:11PM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts4455
Avg. Estimate-0.040.01-0.110.58
Low estimate-0.12-0.05-0.46-0.21
High estimate0.090.120.451.15
Year ago EPS0.21-0.20.2-0.11
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts3355
Avg. Estimate91.11M102.58M390.21M537.14M
Low estimate88.63M99.28M377.05M489M
High estimate94M107M404M613.11M
Year ago sales71.47M67.05M270.26M390.21M
Sales growth (year/est)27.50%53.00%44.40%37.70%
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS-0.17-0.17-0.14-0.16
Actual EPS0.21-0.20.35-0.25
Difference0.38-0.030.49-0.09
Surprise %223.50%-17.60%350.00%-56.20%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate-0.040.01-0.110.58
7 days ago-0.09-0.03-0.190.55
30 days ago-0.11-0.07-0.160.05
60 days ago-0.11-0.07-0.160.06
90 days ago-0.14-0.15-0.360.35
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 days2223
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesKNSAIndustrySector(s)S&P 500
Current qtr.-119.00%N/AN/AN/A
Next qtr.105.00%N/AN/AN/A
Current year-155.00%N/AN/AN/A
Next year627.30%N/AN/AN/A
Next 5 years (per annum)-104.60%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A